Sign In
Buy BMRN
$56.47
+1.81 (+3.31%)
At Close: Jun 04, 2026
The Global Gamification Market will grow by $ 17.56 bn during 2020-2024
Online Education Market in India 2019-2024, 2020 Report on the $14.33 Billion Industry - ResearchAndMarkets.com
12:00am, Tuesday, 15'th Sep 2020
The
Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q2 2020 Update
10:49am, Friday, 11'th Sep 2020
Halvorsen's 13F portfolio value increased from $19.21B to $23.14B. The number of positions increased from 64 to 71.
BioMarin Declining Factor Levels Unlikely To Impact Uniqure Or Sangamo Phase 3 Hemophilia Trials
10:26am, Wednesday, 26'th Aug 2020
BioMarin BLA for Valrox received a CRL last week. Two years of data is now needed before resubmission.
Regenerative Medicine: Does BioMarin Complete Response Letter Change The Outlook?
01:24pm, Tuesday, 25'th Aug 2020
Over a dozen regenerative medicine drugs have been launched, generating revenues approaching $4 billion in 2019.
BioMarin Pharmaceuticals: Appealing After A Pipeline Setback
12:36pm, Monday, 24'th Aug 2020
BioMarin has seen a big setback in approval of its hemophilia A candidate, although it might just be a delay.
Turning Point Solid Tumor Data, And Other News: The Good, Bad And Ugly Of Biopharma
08:26am, Saturday, 22'nd Aug 2020
Turning Point reports positive data for tumor drug candidate. BioMarin faces setback for Hemophilia A therapy.
BioMarin: Not Approved Until It's Approved
12:47am, Thursday, 20'th Aug 2020
The FDA wants to see two more years of data to see how far the Factor VIII levels drop, a primary endpoint of annualized bleeding rate, and safety monitoring as well.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BioMarin Pharmaceutical Inc. - BMRN
10:47pm, Wednesday, 19'th Aug 2020
Pomerantz LLP is investigating claims on behalf of investors of BioMarin Pharmaceutical Inc. ("BioMarin" or the "Company") (NASDAQ: BMRN). Such investors are advised to contact Robert S. Willoughby at
Nasdaq Falls Off Record Levels; Momenta, BioMarin Head in Opposite Directions
08:36pm, Wednesday, 19'th Aug 2020
The Nasdaq Composite (NASDAQINDEX: ^IXIC) has been at record levels, but a late afternoon decline prevented the index from hitting a third straight all-time high. The Federal Reserve's release of min
Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of BioMarin Pharmaceutical Inc. (BMRN) Investigation
07:45pm, Wednesday, 19'th Aug 2020
NEW YORK, NY / ACCESSWIRE / August 19, 2020 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of BioMarin Pharmaceutical Inc.
BioMarin Tanks 36% As FDA Rejects Hemophilia A Gene Therapy Application
06:44pm, Wednesday, 19'th Aug 2020
Shares in BioMarin Pharmaceutical plunged 36% after the US Food and Drug Administration (FDA) in a surprise move rejected the biotech company’s license application for its gene therapy to treat seve
Here's Why BioMarin Pharmaceutical Plummeted Today
06:19pm, Wednesday, 19'th Aug 2020
Shares of BioMarin Pharmaceutical (NASDAQ: BMRN) are down 35% at 1:41 p.m. EDT because the U.S. Food and Drug Administration issued a complete response letter for the biotech's hemophilia A gene thera
FDA Rejects BioMarin's Hemophilia Gene Therapy
06:09pm, Wednesday, 19'th Aug 2020
Shares of BioMarin Pharmaceutical (NASDAQ: BMRN) were down by more than 35% as of 1:50 p.m. EDT Wednesday after the Food and Drug Administration unexpectedly rejected the company's application for va
Stocks Tiptoe Ahead. News From the Fed Is Next.
05:21pm, Wednesday, 19'th Aug 2020
The minutes from the Fed’s policy-setting meeting at the end of July are due out at 2 p.m. Investors will look closely at the language for insights on how the bank sees the economy, and what it migh
